 |
Continuing Medical Education (CME) is jointly sponsored by the
Vanderbilt School of Medicine and the Association of American Cancer Institutes. |
| Sunday, October 5 |
| 11:00 am |
Meeting Registration Begins |
| 1:30 pm |
Welcome
Mr. Ted Yank
Associate Director for Administration
The Dan L. Duncan Cancer Center of Baylor College of Medicine
|
| 1:40 pm |
How to Develop a Strategic Plan for a Cancer Center
Ms. Diana Carmichael
Principal and Founder
AMC Strategies, LLC
|
| 3:40 pm |
Break |
| 4:00 pm |
CCSG Dos and Don’ts
Dr. George Weiner
Director
Holden Comprehensive Cancer Center,
University of Iowa |
| 4:30 pm |
The CCSG Limited Site Visit: Pros, Cons, and Reviews
Mr. Robert DuWors
Deputy Director, Administration and Finance
Jonsson Comprehensive Cancer Center, UCLA
Ms. Lynda Jacobsen
Director of Administration
UCSF Helen Diller Family Comprehensive Cancer Center and
Cancer Research Institute
|
| 5:00 pm |
CCAF Business Meeting |
| 5:30 pm |
Session ends |
| 6:00 - 7:00 pm |
CCAF Welcome Reception |
|
| Monday, October 6 |
| General Session |
| 7:00 am |
Continental breakfast |
| 7:00 am |
Exhibits Open |
| 8:00 am |
Update – NCI Grants Management Office
Mr. Leo Buscher, Jr.
Chief, Office of Grants Administration
National Cancer Institute |
| 9:00 am |
Update - NCI Clinical Trials Reporting Program
Mr. John Speakman
Associate Director, Center for Bioinformatics and Information Technology
National Cancer Institute
|
| 9:30 am |
Break |
| 9:45 am |
President's Report
Dr. Edward J. Benz, Jr.
AACI President
President and CEO, Dana-Farber Cancer Institute
Executive Director's Report
Ms. Barbara Duffy Stewart
Executive Director, Association of American Cancer Institutes
Treasurer's Report
Mr. Randy Main
Treasurer, Association of American Cancer Institutes
Vice-president and Chief Financial Officer,
Fred Hutchinson Cancer Research Center |
| 10:15 am |
Cancer: Challenges and Opportunities in the 21st Century
Congressional staff will discuss new, comprehensive, cancer-related legislation that is currently under consideration in Congress. The panel discussion will focus on how this legislation can enhance the nation’s cancer centers’ efforts in the priority areas identified by the Cancer Center Directors’ Working Group.
Co-moderator: Dr. Benz
Co-moderator: Dr. John Mendelsohn
President, University of Texas, M.D. Anderson Cancer Center
Panelists:
Dr. Michael A. Caligiuri
Director
The Ohio State University Comprehensive Cancer Center -
James Cancer Hospital & Solove Research Institute
Dr. Stanton L. Gerson
Director, Case Comprehensive Cancer Center
Case Western Reserve University
Ireland Cancer Center at University Hospitals of Cleveland
Dr. H. Kim Lyerly
Director
Duke Comprehensive Cancer Center
Dr. Frank McCormick
Director
UCSF Helen Diller Family Comprehensive Cancer Center and
Cancer Research Institute
Dr. Kavita Patel (invited)
Deputy Staff Director for Health
Senate Committee on Health, Education, Labor and Pensions (HELP)
|
| 11:15 am |
Break |
| 11:30 am |
Adult Survivorship: Cancer Center Programs and Best Practices
Challenges adult cancer survivors face include poor communication and lack of information about follow-up care, access to health insurance, and future insurability, as well as concern about employment and financial issues. The goals of survivorship research include: preventing and controlling misdiagnosis of cancer and adverse treatment-related outcomes such as late effects of treatment, second cancers, and poor quality of life; developing guidelines for follow-up care and surveillance of cancers; and optimizing health after treatment.
Each speaker will present their cancer center’s set of instructions for building an adult survivorship program and clinic. Experts will discuss highly developed care models that allow for survivorship research. Topics are adult survivorship and best practices, including strategies for improving the interface between oncologists and primary care physicians, for using data to build an infrastructure for research, and for assuring long-term and late-effect follow-up.
Dr. Linda Jacobs
Director, Living Well After Cancer™
Program
Director, LIVESTRONG™ Survivorship Center of Excellence
Abramson Cancer Center, University of Pennsylvania
Dr. Lawrence N. Shulman
Chief Medical Officer,
Senior Vice President for Medical Affairs
Chief, Division of General Oncology
Dana-Farber Cancer Institute
Dr. Charles L. Shapiro
Professor of Internal Medicine
The Ohio State Comprehensive Cancer Center -
James Cancer Hospital & Solove Research Institute |
| 12:30 pm |
AACI Awards Luncheon
2008 AACI Distinguished Service Award
Dr. Joseph V. Simone
Director,
University of Florida Shands Cancer Center |
| 2:00 pm |
Barriers to Successful Oncology Drug Development
Dr. Tomas J. Philipson
Daniel Levin Professor of Public Policy Studies
Irving B. Harris Graduate School of Public Policy Studies
The University of Chicago Institute |
| 3:00 pm |
Break |
| 3:15 pm |
Cancer Health Care Disparities
Differences in cancer incidence, prevalence, mortality, and survivorship, as well as the burden of cancer or related health conditions exist among racial, ethnic, and underserved groups in the United States. Experts will discuss complex and interrelated factors that contribute to observed disparities including poor communication, access to health care insurance, and socioeconomic status. The session will examine methods that reduce or eliminate health care disparities and increase patient access to clinical trials.
Introduction: Dr. Steven R. Patierno
Executive Director
George Washington Cancer Institute
Investigating health disparities using clinical trials
Dr. James Dignam
Associate Professor, University of Chicago
Access to health care: Is it enough to reduce disparities in cancer prevention?
Dr. Karen M. Emmons
Professor of Society, Human Development, and Health
Dana-Farber Cancer Institute / Harvard School of Public Health
Agenda and future goals of NCI's Center to Reduce Health Disparities
Chair: Dr. Sanya Springfield
Chief, Comprehensive Minority Biomedical Branch
National Cancer Institute
Panel Discussion
Co-moderators: Drs. Patierno and Springfield
Panelists: Drs. Dignam and Emmons
|
| 4:45 pm |
Session ends |
| 6:00 - 7:30 pm |
President's Reception |
| Tuesday, October
7 |
| 7:00 am |
Continental Breakfast |
| 7:00 am |
Exhibits Open |
| General Session |
| 8:00 am |
Report from the National Cancer Institute
Dr. John E. Niederhuber
Director,
National Cancer Institute |
| 8:30 am |
Cancer Center Investments in New Science:
Biomarkers, Imaging, and Tissue Banks
Investigators will introduce new opportunities for biomarkers, imaging, and tissue banks in cancer research and will discuss cancer center investments that would support development of these new scientific areas. The session will look at policy and regulatory issues; infrastructure necessary for program and shared resource development, including bioinformatics infrastructure; and utilization of the new technologies.
Chair: Dr. Donald L. Trump
President and CEO, Roswell Park Cancer Institute
Dr. Samir Hanash
Program Head, Molecular Diagnostics
Fred Hutchinson Cancer Research Center
Dr. Michael V. Knopp
Chairman, Department of Radiology
Novartis Chair of Imaging Research
The Ohio State University
Director, Wright Center of Innovation in Biomedical Imaging
Dr. Carl Morrison
Associate Professor
Director of Division of Molecular Pathology
Department of Pathology Roswell Park Cancer Institute |
| 9:45 am |
Break |
| 10:00 am |
States’ Investments in Cancer Research
Speakers will present successful strategies for securing state legislatures’ investment in cancer centers.
Chair: Dr. Cheryl Willman
Director and C.E.O.
University of New Mexico Cancer Research and Treatment Center
Mr. Mark Moreno
Vice President for Governmental Relations
The University of Texas MD Anderson Cancer Center
Dr. H. Shelton Earp
Director, Lineberger Comprehensive Cancer Center
University of North Carolina, Chapel Hill
|
| 11:00 am |
Adjourn |
11:30
am -
1:30 pm |
Program for Emerging Centers
Experienced cancer center leaders share successful strategies for developing robust research programs and building cancer centers with colleagues’ leading new and emerging cancer centers. This special session will discuss optimizing resources and sustaining growth and development in cancer centers.
Chair: Dr.
John C. Ruckdeschel
President, Director & CEO
Barbara Ann Karmanos Cancer Institute, Wayne State University
Speaker and Panelist: Dr. Joseph V. Simone
Director, University of Florida Shands Cancer Center
Panelists:
Dr. Kevin J. Cullen
Director, University of Maryland Greenebaum Cancer Center
Dr. Beverly Mitchell
Director,
Stanford Cancer Center
Dr. C. Kent Osborne
Director, The Dan L. Duncan Cancer Center at the
Baylor College of Medicine
Dr. Cheryl L. Willman
Director, University of New Mexico Cancer Center
|
| |
Program subject to change
|
CONTINUING MEDICAL EDUCATION
CME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Vanderbilt School of Medicine and AACI. Vanderbilt School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CME (Physicians) Designation Statement
Vanderbilt School of Medicine designates this educational activity for a maximum of 14.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Statement of Educational Need, Target Audience
and Learning Objectives
Leaders from the cancer research community will examine issues that both challenge and contribute to the cancer centers’ combined efforts to improve the health of patients and families in every community across the United States. This trans-disciplinary conference is designed for basic and clinical scientists, as well as for physician-scientists from academia, industry, government, and other institutions with interest in innovative systems and technologies for diagnosing, preventing, and treating cancer and its long-term effects.
Following this learning activity, physician participants will be able to:
• Reduce health care disparities—including those related to poor communication, access to health care insurance, and socioeconomic status—and increase patient access to clinical trials;
• Become familiar leaders with new opportunities for biomarkers, imaging, and tissue banks in cancer research and implement cancer center investments that would support development of these new scientific areas;
• Understand cancer centers’ role in addressing the expected shortage in the nation’s oncology workforce and implement programs at the centers to ensure that sufficient cancer researchers, clinicians, and other health professionals are trained to meet the expected burden of cancer in the U.S.; and
• Recognize the challenges adult cancer survivors experience and understand that research is addressing these issues; come away with a cancer center model and toolkit for building an adult survivorship program and clinic.
Disclosure Statement
It is the policy of Vanderbilt School of Medicine that participants in CME activities be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Each speaker has completed and signed a conflict of interest statement. The faculty members’ relationships will be disclosed to the audience.
Americans with Disabilities Act
It is the policy of Vanderbilt School of Medicine and AACI not to discriminate against any person on the basis of disabilities. If you feel you need services or auxiliary aids mentioned in this act in order to fully participate in this continuing education activity, please call Jaime Anderson at 412-647-3845 or attach a note to your registration form.
|
| |
|
|